Persistent Positivity of Reverse Transcriptase-Polymerase Chain Reaction Test among Patients with COVID-19 in Rural Teaching Hospital: A Descriptive Cross-sectional Study.


Journal

JNMA; journal of the Nepal Medical Association
ISSN: 1815-672X
Titre abrégé: JNMA J Nepal Med Assoc
Pays: Nepal
ID NLM: 0045233

Informations de publication

Date de publication:
15 Nov 2021
Historique:
received: 06 09 2021
accepted: 17 11 2021
entrez: 24 2 2022
pubmed: 25 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

The persistence positivity detected for severe acute respiratory syndrome coronavirus 2 ribonucleic acid by real-time reverse transcriptase-polymerase chain reaction test in asymptomatic coronavirus disease 2019 positive patients has attracted a lot of attention. There is limited data on the duration of viral shedding. We aimed to determine the proportion of coronavirus disease patients with persistent positivity of real-time reverse transcriptase-polymerase chain reaction test in a teaching hospital of Nepal. A descriptive cross-sectional study was conducted using medical records from May to September 2020 in a teaching hospital of Nepal. The study was approved by the Institutional Review Committee of Karnali Academy of Health Sciences (Reference no 077/078/03). Convenient sampling method was used. Data was analysed by Statistical Package for the Social Sciences. Point estimate at 90% Confidence Interval was calculated along with frequency and proportion for binary data. Of the total 95 cases, 9 (9.5%) cases (4.6-14.4 at 90% Confidence Interval), were repeat positive after achieving the first negative. The mean day required of achieving the last negative for the repeat positive group was 62.11±3.95, range (60-70 days). The mean time duration for the virus shedding was found to be 20.43±12.19 days (range 7-60 days) after the first positive test result. This study concludes that there might be a persistent positivity of the polymerase chain reaction test among patients with COVID-19. The majority of the patients were test positive for 8-14 days, and some were positive till 60-70 days.

Identifiants

pubmed: 35199749
doi: 10.31729/jnma.7077
pmc: PMC9124342
doi:

Substances chimiques

RNA-Directed DNA Polymerase EC 2.7.7.49

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1136-1140

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
J Med Virol. 2020 Oct;92(10):2227-2231
pubmed: 32484958
Infect Dis (Lond). 2021 Jan;53(1):31-37
pubmed: 32935628
BMJ Case Rep. 2021 Mar 3;14(3):
pubmed: 33658220
Microorganisms. 2020 Jul 26;8(8):
pubmed: 32722621
J Infect. 2020 May;80(5):e14-e17
pubmed: 32171867
QJM. 2020 Aug 1;113(8):556-560
pubmed: 32609360
Acute Med Surg. 2020 Jun 10;7(1):e525
pubmed: 32528710
J Med Virol. 2020 Oct;92(10):1755-1756
pubmed: 32270882
J Infect. 2020 Jul;81(1):e78-e79
pubmed: 32283161
J Med Case Rep. 2020 Oct 7;14(1):191
pubmed: 33028403
Biomed Res Int. 2021 Feb 26;2021:5909612
pubmed: 33728332
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Am J Infect Control. 2021 Mar;49(3):293-298
pubmed: 32827597
Clin Infect Dis. 2020 Jul 28;71(15):799-806
pubmed: 32271376
JNMA J Nepal Med Assoc. 2020 Nov 22;58(231):918-922
pubmed: 34506421
J Clin Virol. 2020 Aug;129:104477
pubmed: 32505778
JAMA. 2020 Apr 21;323(15):1502-1503
pubmed: 32105304
Ann Transl Med. 2020 Sep;8(17):1084
pubmed: 33145303
Clin Microbiol Infect. 2020 Nov;26(11):1556.e1-1556.e6
pubmed: 32653662

Auteurs

Narayani Maharjan (N)

Program & Department of Clinical Laboratory Medicine, Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China and Department of Molecular Laboratory, Karnali Academy of Health Sciences, Jumla, Nepal.

Niresh Thapa (N)

Department of General Practice and Emergency Medicine, Karnali Academy of Health Sciences, Jumla, Nepal.

Bibek Pun Magar (B)

Department of Clinical Biochemistry, Karnali Academy of Health Sciences, Jumla, Nepal.

Muna Maharjan (M)

School of Nursing and Midwifery, Karnali Academy of Health Sciences, Jumla, Nepal.

Jiancheng Tu (J)

Program & Department of Clinical Laboratory Medicine, Center for Gene Diagnosis, Zhongnan Hospital of Wuhan University, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH